AKBA vs ZBH · rev $102.7M vs P/E 23, rev $4.26B
Akebia Ther (AKBA) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
AKBA currently screens at market cap $260.1M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the AKBA and ZBH stock pages for the full models.
Not investment advice.